The Indian health ministry is planning to make marketers responsible for the quality of the medicines they sell.
Under the Drugs and Cosmetics Rules, manufacturers are liable for the quality of medicines sold in India. The current system means a marketer can source a drug from a third-party manufacturer and put it on the market without being responsible for the quality of the product. If adopted, the revision proposed this week would change that.
“Any marketer who sells or distributes any drug shall be responsible for quality of that drug as well as other regulatory compliances along with the manufacturer under these rules,” the draft proposal states.